Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells

International Immunology

Volumn 20, Issue 9, 2008, Pages 1219-1229

  Shiraishi, Hiroshi ^a   Yoshida, Hideyuki ^a   Saeki, Kazuko ^a   Miura, Yoshiki ^b   Watanabe, Satoko ^a   Ishizaki, Takuma ^a,c   Hashimoto, Masayuki ^a   Takaesu, Giichi ^a   Kobayashi, Takashi ^a   Yoshimura, Akihiko ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibroblast; Lipid mediators; Lipopolysaccharide; Stromal cell; Toll like receptor

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EMBRYO; ENZYME INHIBITION; FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; INFLAMMATION; METABOLISM; SOLUBILITY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; FIBROBLASTS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; SOLUBILITY; STROMAL CELLS;

EID: 53749083198     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn078     Document Type: Article

References (69)

1. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Gutcher, I. and Becher, B. 2007. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 117:1119.
3. Morelli, A. E. and Thomson, A. W. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7:610.
4. Sato, K., Yamashita, N., Yamashita, N., Baba, M. and Matsuyama, T. 2003. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18:367.
5. Verginis, P., Li, H. S. and Carayanniotis, G. 2005. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol. 174:7433.
6. Menges, M., Rossner, S., Voigtlander, C. et al. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:15.
7. Hackstein, H. and Thomson, A. W. 2004. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4:24.
8. Buckley, C. D., Pilling, D., Lord, J. M., Akbar, A. N., Scheel-Toellner, D. and Salmon, M. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22:199.
9. Saalbach, A., Klein, C., Sleeman, J. et al. 2007. Dermal fibroblasts induce maturation of dendritic cells. J. Immunol. 178:4966.
10. Zhang, M., Tang, H., Guo, Z. et al. 2004. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat. Immunol. 5:1124.
11. Svensson, M., Maroof, A., Ato, M. and Kaye, P. M. 2004. Stromal cells direct local differentiation of regulatory dendritic cells. Immunity 21:805.
12. Brouty-Boye, D., Pottin-Clemenceau, C., Doucet, C., Jasmin, C. and Azzarone, B. 2000. Chemokines and CD40 expression in human fibroblasts. Eur. J. Immunol. 30:914.
13. Hogaboam, C. M., Steinhauser, M. L., Chensue, S. W. and Kunkel, S. L. 1998. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int. 54:2152.
14. Pap, T., Muller-Ladner, U., Gay, R. E. and Gay, S. 2000. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2:361.
15. Berthier, R., Rizzitelli, A., Martinon-Ego, C. et al. 2003. Fibroblasts inhibit the production of interleukin-12p70 by murine dendritic cells. Immunology 108:391.
16. Uccelli, A., Moretta, L. and Pistoia, V. 2006. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 36:2566.
17. Djouad, F., Charbonnier, L. M., Bouffi, C. et al. 2007. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025.
18. Beyth, S., Borovsky, Z., Mevorach, D. et al. 2005. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214.
19. Aggarwal, S. and Pittenger, M. F. 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815.
20. Pinzon-Charry, A., Maxwell, T. and Lopez, J. A. 2005. Dendritic cell dysfunction in cancer: A mechanism for immunosuppression. Immunol. Cell Biol. 83:451.
21. Gabrilovich, D. 2004. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4:941.
22. Yu, H., Kortylewski, M. and Pardoll, D. 2007. Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7:41.
23. Yu, S., Liu, C., Su, K. et al. 2007. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J. Immunol. 178:6867.
24. Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T. and Akira, S. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:4652.
25. Kimura, A., Kinjyo, I., Matsumura, Y. et al. 2004. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J. Biol. Chem. 279:6905.
26. Hanada, T., Tanaka, K., Matsumura, Y. et al. 2005. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J. Immunol. 174:4325.
27. Lu, Y., Fukuyama, S., Yoshida, R. et al. 2006. Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to proapoptotic. J. Biol. Chem. 281:36683.
28. Aki, D., Mashima, R., Saeki, K., Minoda, Y., Yamauchi, M. and Yoshimura, A. 2005. Modulation of TLR signalling by the C-terminal Src kinase (Csk) in macrophages. Genes Cells 10:357.
29. Matsumura, Y., Kobayashi, T., Ichiyama, K. et al. 2007. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J. Immunol. 179:2170.
30. Steinman, R. M., Turley, S., Mellman, I. and Inaba, K. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411.
31. Ip, W. K. and Lau, Y. L. 2004. Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J. Immunol. 173:189.
32. Akira, S., Uematsu, S. and Takeuchi, O. 2006. Pathogen recognition and innate immunity. Cell 124:783.
33. Campbell, J., Ciesielski, C. J., Hunt, A. E. et al. 2004. A novel mechanism for TNF-alpha regulation by p38 MAPK: Involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J. Immunol. 173:6928.
34. Agrawal, A., Dillon, S., Denning, T L. and Pulendran, B. 2006. ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176:5788.
35. Bharadwaj, U., Li, M., Zhang, R., Chen, C. and Yao, Q. 2007. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 67:5479.
36. Cheng, F., Wang, H. W., Cuenca, A. et al. 2003. A critical role for Stat3 signaling in immune tolerance. Immunity 19:425.
37. Wang, S., Miyazaki, Y., Shinozaki, Y. and Yoshida, H. 2007. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J. Immunol. 179:6421.
38. Laouar, Y., Welte, T., Fu, X. Y. and Flavell, R. A. 2003. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19:903.
39. van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J. and Aarden, L. A. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775.
40. Rimoldi, M., Chieppa, M., Salucci, V. et al. 2005. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6:507.
41. Newberry, R. D., McDonough, J. S., Stenson, W. F. and Lorenz, R. G. 2001. Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: Directing the tone of the intestinal immune response. J. Immunol. 166:4465.
42. Newberry, R. D., Stenson, W. F. and Lorenz, R. G. 1999. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat. Med. 5:900.
43. Sa-Nunes, A., Bafica, A., Lucas, D. A. et al. 2007. Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva. J. Immunol. 179:1497.
44. Harris, S. G., Padilla, J., Koumas, L., Ray, D, and Phipps, R. P. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23:144.
45. Kalinski, P., Vieira, P. L., Schuitemaker, J. H., de Jong, E. C. and Kapsenberg, M. L. 2001. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97:3466.
46. Kabashima, K., Murata, T., Tanaka, H. et al. 2003. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4:694.
47. Zhou, W., Hashimoto, K., Goleniewska, K. et al. 2007. Prostaglandin 12 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J. Immunol. 178:702.
48. Faveeuw, C., Gosset, P., Bureau, F. et al. 2003. Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur. J. Immunol. 33:889.
49. Appel, S., Mirakaj, V., Bringmann, A., Weck, M. M., Grunebach, F. and Brossart, P. 2005. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 106:3888.
50. Guyton, K., Bond, R., Reilly, C., Gilkeson, G., Halushka, P. and Cook, J. 2001. Differential effects of 15-deoxy-delta(12, 14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. J. Leukoc. Biol. 69:631.
51. Kita, Y., Takahashi, T., Uozumi, N. and Shimizu, T. 2005. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Biochem. 342:134.
52. Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M. and Uchida, K. 2002. 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J. Biol. Chem. 277:10459.
53. Sugimoto, Y. and Narumiya, S. 2007. Prostaglandin E receptors. J. Biol. Chem. 282:11613.
54. Martin, M., Rehani, K., Jope, R. S. and Michalek, S. M. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6:777.
55. Parry, G. C. and Mackman, N. 1997. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J. Immunol. 159:5450.
56. Sheibanie, A. F., Tadmori, I., Jing, H., Vassiliou, E. and Ganea, D. 2004. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18:1318.
57. Sheibanie, A. F., Yen, J. H., Khayrullina, T. et al. 2007. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J. Immunol. 178:8138.
58. Muthian, G., Raikwar, H. P., Johnson, C. et al. 2006. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis. J. Clin. Immunol. 26:73.
59. Pollak, Y., Ovadia, H., Orion, E. and Yirmiya, R. 2003. The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments. J. Neuroimmunol. 137:100.
60. Lucas, M., Stuart, L. M., Zhang, A. et al. 006. Requirements for apoptotic cell contact in regulation of macrophage responses. J. Immunol. 177:4047.
61. Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R. and Girkontaite, I. 1997. Immunosuppressive effects of apoptotic cells. Nature 390:350.
62. Kim, S., Elkon, K. B. and Ma, X. 2004. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21:643.
63. Travis, M. A., Reizis, B., Melton, A. C. et al. 2007. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449:361.
64. Collins, A. V., Brodie, D. W., Gilbert, R. J. et al. 2002. The interaction properties of costimulatory molecules revisited. Immunity 17:201.
65. Zheng, Y., Manzotti, C. N., Liu, M., Burke, F., Mead, K. I. and Sansom, D. M. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172:2778.
66. Gallucci, S., Lolkema, M. and Matzinger, P. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249.
67. Scaffidi, P., Misteli, T. and Bianchi, M. E. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191.
68. Shi, Y., Evans, J. E. and Rock, K. L. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516.
69. Albert, M. L. 2004. Death-defying immunity: Do apoptotic cells influence antigen processing and presentation? Nat. Rev. Immunol. 4:223.